Immune Landscape of Thoracic Malignancies (H-35782)

The purpose of this clinical trial is to collect information on the types of immune cells found in and around the tumor site(s). This information will tell us how a patient’s immune system is reacting to the presence of the tumor. When we combine this information with other information on patients’ prognoses, we will be able to identify the types of immune responses seen in patients that recover well from mesothelioma. The goal of learning this information is to explore the possibility of manipulating the immune system to favor improved prognosis using additional drugs or other therapies.